Rituximab-Induced Coronary Vasospasm

Rituximab has improved the treatment of B-cell non-Hodgkin lymphomas. While it is generally well tolerated, serious adverse effects including infusion reactions with hemodynamic compromise and cardiac arrhythmias or ischemia are possible. We report a case of coronary vasospasm occurring during a rit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Linda, Kukreti, Vishal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420582/
https://www.ncbi.nlm.nih.gov/pubmed/22953082
http://dx.doi.org/10.1155/2012/984986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420582/
https://www.ncbi.nlm.nih.gov/pubmed/22953082
http://dx.doi.org/10.1155/2012/984986

Ejemplares similares